Revvity, Inc. (RVTY), headquartered in Waltham, Massachusetts, is a leading provider of health sciences solutions, technologies, and diagnostic services. Valued at $13.9 billion by market cap, the company focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and other areas.
Shares of this leading research and diagnostic firm have outperformed the broader market over the past year. RVTY has gained 39.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.5%. In 2026, RVTY's stock rose 28.9%, surpassing the SPX's 12.1% rise on a YTD basis.
Soros Fund Management Opened a New Position in Nebius During Q2. What This Means for NBIS Stock.
Nvidia Earnings, Jackson Hole and Other Key Things to Watch this Week
Ahead of Nvidia Earnings, Here's What Barchart Data Says Comes Next for NVDA Stock

#Stock #rvty #diagnostic #revvity